Skip to main content
OpenTrials
Completed

NCT Number: NCT03857334

Efficacy of Platelet Rich Plasma in Plantar Fasciitis

Plantar fasciitis is a common pathology among podiatry moreover the healing time takes several months.

The main aim of this study is to evaluate the efficacy of a injection of Platelet-Rich Plasma (PRP) versus corticosteroid injection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Montpellier University Hosîtal

Montpellier, 34090, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Plantar fasciitis
  • Average VAS greater than or equal to 5/10
  • Resistance of medical reference treatment

Exclusion criteria

  • Other plantar lesion find on RMI
  • Pregnancy

Treatment and study plan

Injection of autologous platelet rich plasma

Biological

Injection of cortivazol : Altim®

Drug

Corticosteroids

Primary outcomes

  1. Mean daily pain measured with a visual analog scale from 0 to 10

    Time frame: 6 months

    Comparison of pain intensity, measured with a visual analog scale from 0 to 10

Secondary outcomes

  1. Pain intensity during the first steps of the day measured with a visual analog scale from 0 to 10

    Time frame: 6 months

    Measured with a visual analog scale from 0 to 10

  2. Pain intensity on direct compression measured with a visual analog scale from 0 to 10

    Time frame: 6 months

    Constant intensity of the compression, measured with a visual analog scale from 0 to 10

  3. Impairment of walking function

    Time frame: 6 months

    Foot function index

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Plantar Fasciitis Treatment: Double Blinded Randomized Control Study of the Efficacy of an Injection of Platelet Rich Plasma (PRP) Versus an Infiltration of Corticosteroids

Acronym: APOPLANT

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Feb 27, 2019
Registry last updated
Feb 27, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.